Abstract
Diabetic maculopathy is an important cause of severe sight impairment. There has been a significant evolution in its treatment over the past decade and laser treatment is now largely being superseded by intravitreal injections of anti-vascular endothelial growth factor agents or corticosteroids.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have